How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview.
Saved in:
| Title: | How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview. |
|---|---|
| Authors: | Empeslidis T; Medical Retina Department, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, UK., Storey M; Medical Retina Department, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, UK., Giannopoulos T; 1st Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece., Konidaris V; Medical Retina Department, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, UK., Tranos PG; Ophthalmica Eye Institute, Thessaloniki, Greece., Panagiotou ES; 1st Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece., Voudouragkaki IC; 1st Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece., Konstas AG; 1st and 3rd University Departments of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece. konstas@med.auth.gr. |
| Source: | Advances in therapy [Adv Ther] 2019 Jul; Vol. 36 (7), pp. 1532-1548. Date of Electronic Publication: 2019 May 17. |
| Publication Type: | Journal Article; Systematic Review |
| Journal Info: | Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
